Annual Meeting

Shifting gears to find the right path

Rebecca Haeusler will speak at the ASBMB annual meeting’s Journal of Lipid Research session
Himanshi Bhatia
Feb. 16, 2022

Rebecca Haeusler is an expert in metabolic diseases and an associate professor at Columbia University Irving Medical Center, but her career trajectory has been far from straightforward.

Rebecca Haeusler

Growing up in Michigan, Haeusler decided on engineering as a career prospect. While pursuing her undergraduate degree at the Massachusetts Institute of Technology, however, she had a change of heart.

“I attended MIT thinking I would go into engineering,” she said, “but I changed my mind when I got bit by the biological sciences bug.”

Haeusler worked as a research associate before starting her Ph.D. in biological chemistry at the University of Michigan. There, she learned to think critically, she said, and to work as part of a research team studying transfer RNAs in yeast. Although basic research was exciting, her thesis topic was far removed from any real-world application. “I felt compelled to move into a topic more closely related to human health and disease,” she said.

Her aspirations soared when Haeusler worked on a grant where trainees designed a semester-long course, choosing the topic, inviting outside speakers and leading weekly journal clubs and discussions. “I ended up reading articles on insulin and leptin signaling that strongly sparked my interest,” she said.

She became interested in metabolic diseases and changed research topics when she entered her postdoctoral training period in Domenico Accili’s lab at Columbia University.

This change came with challenges. Haeusler had to learn new techniques and change her entire thought process to encompass multiple organs instead of individual cells — all while trying to prove her mettle in a new lab. One-on-one mentoring with her PI and support of her colleagues helped her succeed and excel, she said.

Looking back, she said that being honest to yourself and letting go of pride and ego are the keys to success. “When I was working as a technician before graduate school, my boss called me out for not asking for help when I needed it,” she said. “The lesson sticks with me, and I still strive to apply it every day.”

A focus on lipoproteins and bile acids

When a person becomes obese or insulin resistant or is diagnosed with Type 2 diabetes, their body’s ability to metabolize lipids and cholesterol changes. As many people become hyperfocused on healthy living and body weight, understanding the root causes of metabolic disease progression assumes a special role.

Rebecca Haeusler’s lab aims to increase that understanding by focusing on lipoproteins and bile acids. Lipoproteins are complexes that transport cholesterol through the blood stream, while bile acids are involved in the digestion of fat. Both are dysregulated in insulin resistance, diabetes and obesity.

Bile acid composition is altered by numerous physiological and pathophysiological states, interventions and medications, leading to metabolic consequences that are particularly difficult to tease apart in humans. To learn about these consequences, Haeusler’s lab uses mice that have humanized bile acid composition. Recent work has shown that, contrary to expectations, the presence of muricholic acids (abundant in mice and rats but not humans) does not protect against high fat diet–induced obesity, glucose intolerance and liver fat accumulation, suggesting that additional research is needed to understand the effects of bile acid composition on the body and molecular mechanisms.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Himanshi Bhatia

Himanshi Bhatia is a postdoctoral research associate at the Washington University in St. Louis and is passionate about science communication.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Ralph G. Yount
In Memoriam

In memoriam: Ralph G. Yount

July 28, 2025

He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.